Issue 5

Will 2024 be The Year of Biotech IPOs and M&As?

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY 

Is 2024 the Year for Resurgence in the Biotech Sector?

With a notable shift in industry dynamics, increasing investments, and innovative breakthroughs, it appears we are witnessing signs of a significant resurgence. Prior to the COVID-19 pandemic, the global biotech sector saw robust growth and drew substantial investment, as investors were captivated by the potential of breakthrough treatments and technological advancements. This positive momentum laid the groundwork for what would become an explosive period for biotech, accelerated by the need for a rapid response to the pandemic.

Read more here.

FEATURED STORIES

Drugs Losing Exclusivity in 2024

Read more here.

Novo Nordisk’s Wegovy Approved by the FDA for Heart Attack & Stroke Prevention

Read more here.

LSD Treatment Receives Breakthrough Therapy Status for Anxiety

Read more here.

FDA Issues Warning Letters for Data Integrity Breaches in Global Pharma Manufacturing

Read more here.

MHRA Fast-Tracks Approval of New XGEVA Formulation via International Recognition Procedure

Read more here.

MHRA Unveils New Guidance to Accelerate Assessment of Established Medicines

Read more here.

Eli Lilly Partners with Amazon Pharmacy to Deliver Medication Via LillyDirect

Read more here.

Nvidia Invests $35 Million into Biotech Technology Company

Read more here.

Tierra Biosciences Completes Series A for Predictive AI Protein Platform

Read more here.

Adare Pharma Solutions to Expand Oral Dose Packaging and Warehousing Capabilities in Europe

Read more here.

Novo Nordisk Outlines Strategy 2030, Plan for Catalent Acquisition & Future Focus

Read more here.

More Job Layoffs Announced

Read more here.

Akari Therapeutics & Peak Bio Announce Merger

Read more here.

Aspire Pharma Acquires Cenoté Pharma

Read more here.

South Africans Take on Pharmaceutical Company Vertex

Read more here.

Novartis Set to Expand Antibody Production in Singapore

Read more here.